MRK logo

Merck & Co (MRK) Free Cash Flow

Annual FCF

$9.14 B
-$5.56 B-37.83%

31 December 2023

MRK Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly FCF

$8.51 B
+$3.66 B+75.57%

30 September 2024

MRK Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM FCF

$14.84 B
+$1.69 B+12.88%

30 September 2024

MRK TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRK Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-37.8%+24.8%+12.7%
3 y3 years+57.0%+134.7%+76.4%
5 y5 years+10.1%+160.4%+65.4%

MRK Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-37.8%+57.0%at high+1245.1%-2.7%+76.4%
5 y5 years-37.8%+57.0%at high+1245.1%-2.7%+169.0%
alltimeall time-37.8%+864.8%at high+436.9%-2.7%+3563.3%

Merck & Co Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
$8.51 B(+75.6%)
$14.84 B(+12.9%)
June 2024
-
$4.85 B(+117.4%)
$13.15 B(+19.1%)
Mar 2024
-
$2.23 B(-400.0%)
$11.04 B(+20.7%)
Dec 2023
$9.14 B(-37.8%)
-$743.00 M(-110.9%)
$9.14 B(-30.6%)
Sept 2023
-
$6.82 B(+148.8%)
$13.17 B(+21.6%)
June 2023
-
$2.74 B(+725.0%)
$10.83 B(-3.9%)
Mar 2023
-
$332.00 M(-89.9%)
$11.26 B(-23.4%)
Dec 2022
$14.71 B(+52.2%)
$3.28 B(-26.7%)
$14.71 B(-3.6%)
Sept 2022
-
$4.48 B(+41.1%)
$15.25 B(+5.9%)
June 2022
-
$3.17 B(-16.0%)
$14.40 B(+13.1%)
Mar 2022
-
$3.78 B(-1.2%)
$12.73 B(+31.8%)
Dec 2021
$9.66 B(+65.9%)
$3.82 B(+5.5%)
$9.66 B(+14.8%)
Sept 2021
-
$3.63 B(+141.0%)
$8.41 B(+52.5%)
June 2021
-
$1.50 B(+112.1%)
$5.52 B(-19.0%)
Mar 2021
-
$709.00 M(-72.5%)
$6.81 B(+17.0%)
Dec 2020
$5.82 B(-42.2%)
$2.58 B(+253.7%)
$5.82 B(-16.9%)
Sept 2020
-
$728.00 M(-74.0%)
$7.01 B(-26.6%)
June 2020
-
$2.80 B(-1103.6%)
$9.55 B(+5.5%)
Mar 2020
-
-$279.00 M(-107.4%)
$9.05 B(-10.1%)
Dec 2019
$10.07 B(+21.2%)
$3.76 B(+15.1%)
$10.07 B(+12.2%)
Sept 2019
-
$3.27 B(+41.9%)
$8.97 B(+14.4%)
June 2019
-
$2.30 B(+210.7%)
$7.85 B(-6.0%)
Mar 2019
-
$741.00 M(-72.2%)
$8.34 B(+0.4%)
Dec 2018
$8.31 B(+82.1%)
$2.66 B(+24.4%)
$8.31 B(-7.2%)
Sept 2018
-
$2.14 B(-23.5%)
$8.95 B(+72.2%)
June 2018
-
$2.80 B(+297.0%)
$5.20 B(-2.3%)
Mar 2018
-
$705.00 M(-78.7%)
$5.32 B(+16.6%)
Dec 2017
$4.56 B(-47.9%)
$3.30 B(-305.0%)
$4.56 B(+5.1%)
Sept 2017
-
-$1.61 B(-155.1%)
$4.34 B(-49.0%)
June 2017
-
$2.92 B(-5617.0%)
$8.51 B(+24.9%)
Mar 2017
-
-$53.00 M(-101.7%)
$6.82 B(-22.2%)
Dec 2016
$8.76 B(-22.2%)
$3.08 B(+20.3%)
$8.76 B(-7.1%)
Sept 2016
-
$2.56 B(+109.1%)
$9.43 B(-4.4%)
June 2016
-
$1.23 B(-35.3%)
$9.87 B(-10.9%)
Mar 2016
-
$1.89 B(-49.5%)
$11.07 B(-1.7%)
Dec 2015
$11.26 B(+98.4%)
$3.75 B(+25.3%)
$11.26 B(+126.1%)
Sept 2015
-
$3.00 B(+23.5%)
$4.98 B(-17.2%)
June 2015
-
$2.43 B(+16.6%)
$6.01 B(+7.4%)
Mar 2015
-
$2.08 B(-182.4%)
$5.60 B(-1.3%)
Dec 2014
$5.67 B(-43.9%)
-$2.52 B(-162.7%)
$5.67 B(-47.5%)
Sept 2014
-
$4.03 B(+100.1%)
$10.79 B(+4.2%)
June 2014
-
$2.01 B(-6.6%)
$10.36 B(+0.9%)
Mar 2014
-
$2.16 B(-17.0%)
$10.27 B(+1.6%)
Dec 2013
$10.11 B(+25.3%)
$2.60 B(-27.7%)
$10.11 B(+18.3%)
Sept 2013
-
$3.59 B(+86.7%)
$8.54 B(+11.3%)
June 2013
-
$1.93 B(-3.3%)
$7.67 B(-6.8%)
Mar 2013
-
$1.99 B(+93.0%)
$8.23 B(+2.1%)
Dec 2012
$8.07 B(-24.3%)
$1.03 B(-62.2%)
$8.07 B(-16.5%)
Sept 2012
-
$2.73 B(+9.5%)
$9.67 B(-12.8%)
June 2012
-
$2.49 B(+36.5%)
$11.09 B(+0.0%)
Mar 2012
-
$1.82 B(-30.7%)
$11.09 B(+4.0%)
Dec 2011
$10.66 B(+16.6%)
$2.63 B(-36.6%)
$10.66 B(-2.3%)
Sept 2011
-
$4.15 B(+66.7%)
$10.91 B(+21.0%)
June 2011
-
$2.49 B(+78.0%)
$9.02 B(-5.3%)
Mar 2011
-
$1.40 B(-51.5%)
$9.52 B(+4.1%)
Dec 2010
$9.14 B(+373.5%)
$2.88 B(+27.7%)
$9.14 B(+15.0%)
Sept 2010
-
$2.25 B(-24.6%)
$7.95 B(+56.5%)
June 2010
-
$2.99 B(+192.1%)
$5.08 B(+105.2%)
Mar 2010
-
$1.02 B(-39.3%)
$2.48 B(+28.2%)
Dec 2009
$1.93 B(-63.4%)
$1.69 B(-373.8%)
$1.93 B(+121.1%)
Sept 2009
-
-$615.40 M(-260.3%)
$873.30 M(-69.5%)
June 2009
-
$383.80 M(-19.6%)
$2.86 B(-19.8%)
Mar 2009
-
$477.50 M(-23.9%)
$3.56 B(-32.4%)
Dec 2008
$5.27 B(-11.9%)
$627.40 M(-54.2%)
$5.27 B(-21.4%)
Sept 2008
-
$1.37 B(+25.8%)
$6.71 B(-17.3%)
June 2008
-
$1.09 B(-50.2%)
$8.11 B(-16.4%)
Mar 2008
-
$2.19 B(+6.0%)
$9.70 B(+62.1%)
Dec 2007
$5.99 B
$2.06 B(-25.6%)
$5.99 B(+10.8%)
Sept 2007
-
$2.77 B(+3.4%)
$5.41 B(+39.0%)
June 2007
-
$2.68 B(-275.3%)
$3.89 B(+23.6%)
DateAnnualQuarterlyTTM
Mar 2007
-
-$1.53 B(-203.3%)
$3.15 B(-45.6%)
Dec 2006
$5.79 B(-6.8%)
$1.48 B(+17.8%)
$5.79 B(-6.1%)
Sept 2006
-
$1.26 B(-35.1%)
$6.16 B(-9.4%)
June 2006
-
$1.94 B(+74.7%)
$6.80 B(+7.6%)
Mar 2006
-
$1.11 B(-40.3%)
$6.32 B(+1.8%)
Dec 2005
$6.21 B(-12.3%)
$1.86 B(-1.9%)
$6.21 B(+0.1%)
Sept 2005
-
$1.89 B(+29.9%)
$6.20 B(+1.4%)
June 2005
-
$1.46 B(+46.3%)
$6.11 B(-7.1%)
Mar 2005
-
$996.20 M(-46.2%)
$6.58 B(-7.0%)
Dec 2004
$7.07 B(-11.0%)
$1.85 B(+2.4%)
$7.07 B(-5.8%)
Sept 2004
-
$1.81 B(-6.0%)
$7.51 B(-14.8%)
June 2004
-
$1.92 B(+29.0%)
$8.82 B(+9.5%)
Mar 2004
-
$1.49 B(-34.8%)
$8.05 B(+1.3%)
Dec 2003
$7.95 B(+11.0%)
$2.29 B(-26.6%)
$7.95 B(+2.5%)
Sept 2003
-
$3.12 B(+169.0%)
$7.75 B(+8.0%)
June 2003
-
$1.16 B(-16.5%)
$7.18 B(+2.0%)
Mar 2003
-
$1.39 B(-33.6%)
$7.04 B(-1.7%)
Dec 2002
$7.16 B(+20.5%)
$2.09 B(-17.8%)
$7.16 B(+4.8%)
Sept 2002
-
$2.54 B(+150.0%)
$6.83 B(+4.5%)
June 2002
-
$1.02 B(-32.6%)
$6.54 B(+10.6%)
Mar 2002
-
$1.51 B(-14.3%)
$5.91 B(-0.5%)
Dec 2001
$5.94 B(+19.8%)
$1.76 B(-21.7%)
$5.94 B(+6.8%)
Sept 2001
-
$2.25 B(+473.6%)
$5.56 B(+28.4%)
June 2001
-
$392.10 M(-74.5%)
$4.33 B(-11.9%)
Mar 2001
-
$1.54 B(+11.3%)
$4.92 B(-0.8%)
Dec 2000
$4.96 B(+38.9%)
$1.38 B(+36.0%)
$4.96 B(+21.1%)
Sept 2000
-
$1.02 B(+3.7%)
$4.10 B(+2.9%)
June 2000
-
$980.00 M(-38.0%)
$3.98 B(+8.8%)
Mar 2000
-
$1.58 B(+204.1%)
$3.66 B(+2.5%)
Dec 1999
$3.57 B(+6.4%)
$519.50 M(-42.3%)
$3.57 B(-1.9%)
Sept 1999
-
$900.40 M(+36.7%)
$3.64 B(-1.7%)
June 1999
-
$658.70 M(-55.8%)
$3.70 B(+1.7%)
Mar 1999
-
$1.49 B(+153.7%)
$3.64 B(+8.4%)
Dec 1998
$3.35 B(-31.1%)
$588.00 M(-38.9%)
$3.35 B(-21.3%)
Sept 1998
-
$961.70 M(+61.4%)
$4.26 B(-6.1%)
June 1998
-
$595.80 M(-50.7%)
$4.54 B(-6.3%)
Mar 1998
-
$1.21 B(-19.2%)
$4.85 B(-0.5%)
Dec 1997
$4.87 B(+15.1%)
$1.50 B(+20.9%)
$4.87 B(-0.8%)
Sept 1997
-
$1.24 B(+37.2%)
$4.91 B(+5.4%)
June 1997
-
$902.00 M(-26.8%)
$4.66 B(+2.5%)
Mar 1997
-
$1.23 B(-19.9%)
$4.54 B(+7.4%)
Dec 1996
$4.23 B(+118.2%)
$1.54 B(+56.2%)
$4.23 B(+20.7%)
Sept 1996
-
$984.60 M(+24.6%)
$3.50 B(+9.1%)
June 1996
-
$790.40 M(-13.9%)
$3.21 B(+21.5%)
Mar 1996
-
$918.00 M(+13.2%)
$2.64 B(+36.3%)
Dec 1995
$1.94 B(-38.1%)
$811.20 M(+17.1%)
$1.94 B(+5.3%)
Sept 1995
-
$692.60 M(+212.8%)
$1.84 B(-16.5%)
June 1995
-
$221.40 M(+3.7%)
$2.21 B(-22.6%)
Mar 1995
-
$213.50 M(-70.1%)
$2.85 B(-8.9%)
Dec 1994
$3.13 B(+53.8%)
$714.40 M(-32.5%)
$3.13 B(+4.0%)
Sept 1994
-
$1.06 B(+22.0%)
$3.01 B(+10.2%)
June 1994
-
$867.10 M(+76.5%)
$2.73 B(+33.6%)
Mar 1994
-
$491.30 M(-17.3%)
$2.04 B(+0.4%)
Dec 1993
$2.04 B(+41.6%)
$593.90 M(-23.8%)
$2.04 B(+5.2%)
Sept 1993
-
$779.90 M(+335.2%)
$1.94 B(+18.9%)
June 1993
-
$179.20 M(-62.9%)
$1.63 B(+2.5%)
Mar 1993
-
$482.80 M(-2.1%)
$1.59 B(+10.4%)
Dec 1992
$1.44 B(+3.3%)
$493.10 M(+4.5%)
$1.44 B(+8.0%)
Sept 1992
-
$471.80 M(+237.7%)
$1.33 B(+0.1%)
June 1992
-
$139.70 M(-58.1%)
$1.33 B(+5.4%)
Mar 1992
-
$333.20 M(-13.8%)
$1.26 B(-9.4%)
Dec 1991
$1.39 B(+0.6%)
$386.60 M(-17.8%)
$1.39 B(+1.4%)
Sept 1991
-
$470.10 M(+557.5%)
$1.37 B(+10.1%)
June 1991
-
$71.50 M(-84.6%)
$1.25 B(-13.6%)
Mar 1991
-
$464.30 M(+26.2%)
$1.44 B(+4.3%)
Dec 1990
$1.38 B(+46.1%)
$368.00 M(+7.1%)
$1.38 B(+36.2%)
Sept 1990
-
$343.50 M(+28.1%)
$1.02 B(+51.0%)
June 1990
-
$268.20 M(-33.8%)
$673.30 M(+66.2%)
Mar 1990
-
$405.10 M
$405.10 M
Dec 1989
$947.70 M
-
-

FAQ

  • What is Merck & Co annual free cash flow?
  • What is the all time high annual FCF for Merck & Co?
  • What is Merck & Co annual FCF year-on-year change?
  • What is Merck & Co quarterly free cash flow?
  • What is the all time high quarterly FCF for Merck & Co?
  • What is Merck & Co quarterly FCF year-on-year change?
  • What is Merck & Co TTM free cash flow?
  • What is the all time high TTM FCF for Merck & Co?
  • What is Merck & Co TTM FCF year-on-year change?

What is Merck & Co annual free cash flow?

The current annual FCF of MRK is $9.14 B

What is the all time high annual FCF for Merck & Co?

Merck & Co all-time high annual free cash flow is $14.71 B

What is Merck & Co annual FCF year-on-year change?

Over the past year, MRK annual free cash flow has changed by -$5.56 B (-37.83%)

What is Merck & Co quarterly free cash flow?

The current quarterly FCF of MRK is $8.51 B

What is the all time high quarterly FCF for Merck & Co?

Merck & Co all-time high quarterly free cash flow is $8.51 B

What is Merck & Co quarterly FCF year-on-year change?

Over the past year, MRK quarterly free cash flow has changed by +$1.69 B (+24.84%)

What is Merck & Co TTM free cash flow?

The current TTM FCF of MRK is $14.84 B

What is the all time high TTM FCF for Merck & Co?

Merck & Co all-time high TTM free cash flow is $15.25 B

What is Merck & Co TTM FCF year-on-year change?

Over the past year, MRK TTM free cash flow has changed by +$1.67 B (+12.71%)